Global Sirolimus-eluting Stents Market

Global Sirolimus-eluting Stents Market size is expected to reach USD 11.81 Bn. by year 2030 at a CAGR of 5.5% during the forecast period.

Global Sirolimus-eluting Stents Market Overview:

Drug-eluting implants Stents are expandable tubes made of wire that is implanted into the coronary arteries of patients with atherosclerosis to keep the artery open by releasing a drug that prevents the artery from being blocked again and enhances blood flow. Sirolimus is a macrolide drug used to coat coronary stents, prevent organ transplant rejection, and treat rare lung disease.To know about the Research Methodology :- Request Free Sample Report

Global Sirolimus-eluting Stents Market Dynamics:

Increasing cases of cardiovascular diseases is the major factor driving the market growth.

The rising prevalence of cardiovascular diseases and the growing demand for minimally invasive surgeries are the primary factors boosting the market growth. The use of a minimally invasive surgical technique, which is the main growth factor, has resulted in a decline in post-operative trauma and complications. Other benefits of using advanced and miniaturized coronary stents include shorter hospital stays and faster recovery times.

The demand for sirolimus-eluting stents is largely driven by the growing geriatric population, which is at a higher risk of developing arterial disorders. Furthermore, unhealthy eating patterns, sedentary lifestyles, and a lack of exercise raise the prevalence of atherosclerosis globally, propelling the market growth. Advantages associated with Sirolimus stents such as, it is lipid-soluble also known as lipophilic due to which almost no drug is released into the bloodstream during stent implantation at the lesion site, it also favours the diffusion gradient elution into tissue after stent implantation, aids the market growth of Sirolimus-eluting stents. In addition to its antibiotic properties, Sirolimus was discovered to have potent anti-proliferative and anti-inflammatory properties. This factor also adds up to the market growth. Other factors such as increasing novel product launches and FDA approvals, technological advancements and rising investments in research & development propel the market growth.

However, the market growth is being hampered by the declining prices of these devices. Furthermore, drug-eluting stents carry the risk of stent thrombosis and endothelial tissue destruction during regrowth. In the forecast period, these factors are expected to pose a threat to the market's development.

The report has profiled eighteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.

Global Sirolimus-eluting Stents Market Segment Analysis:

The Global Sirolimus-eluting Stents Market is segmented on the basis of Type, Application and End-Users.

Based on the Type, polymer free segment holds the dominant market share. Polymer-free coating stents are made up of Microporous stents and inorganic coatings that can be drug-loaded. Several drugs have been used in the development of carrier-free stents, including tacrolimus, paclitaxel, sirolimus, and probucol. Furthermore, the polymer-free coating has benefits such as eliminating inflammatory problems caused by polymers used in stents and allowing anti-proliferative drugs to be released directly from the stent surface. The growing geriatric population, rising prevalence of cardiovascular diseases, and the demand for minimally invasive procedures are driving the polymer-free coating stents market.

Based on the Application, coronary artery disease segment is expected to dominate the global market during the forecast period. The coronary artery disease segment is expected to grow at a CAGR of 9.3% during forecast years. The American Heart Association states that Coronary artery disease is the leading cause of death in the US, affecting more than 13 million people. In the US, almost 610,000 people die of heart disease per year, accounting for one out of every four deaths. Due to a rise in the prevalence of coronary artery disease, increased use of drug-eluting stents and rising device approvals in the treatment of coronary artery disease boosts the segment growth.

Global Sirolimus-eluting Stents Market Regional Insights:

North America holds the dominant market share.

The North America region is expected to continue the dominance throughout the forecast period. The regional growth is accounted to the growing prevalence of cardiovascular diseases and the government’s support for reimbursement policies. Furthermore, technological advances in drug-eluting stents, as well as the existence of well-established healthcare infrastructure, are both contributing to the overall regional market's growth.

APAC is expected to witness lucrative growth during forecast period.

During the forecast period, India, China, Brazil, and South Africa would have the highest growth rates. Growing awareness of commercial availability of drugs, government financing, constantly developing healthcare facilities, and that healthcare spending are all factors contributing to the market's substantial growth in these countries.

The report also helps in understanding Global Sirolimus-eluting Stents Market dynamics, structure by analyzing the market segments and project the Global Sirolimus-eluting Stents Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Sirolimus-eluting Stents Market make the report investor’s guide.

Global Sirolimus-eluting Stents Market Scope: Inquire before buying

Global Sirolimus-eluting Stents Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)

Global Sirolimus-eluting Stents Market, Key players:

1. STENTYS SA
2. iVascular SLU
3. nano Therapeutics Pvt. Ltd
4. S3V Vascular Technologies
5. Meril Life Sciences Pvt. Ltd.
6. Micell Technologies, Inc.
7. B. Braun Melsungen AG
8. SMT
9. Eurocor Tech GmbH
10. Boston Scientific Corporation
11. Medtronic, Inc.
12. Abbott Laboratories
13. Biosensors International Group
14. Biotronik
15. Lepu Medical Technology
16. Terumo Medical Corporation
17. Cook Medical
18. Shandong JW Medical Systems

Frequently Asked Questions:

1. Which region has the largest share in Global Sirolimus-eluting Stents Market?
Ans: North America region held the highest share in 2023.

2. What is the growth rate of Global Sirolimus-eluting Stents Market?
Ans: The Global Sirolimus-eluting Stents Market is growing at a CAGR of 5.5% during forecasting period 2024-2030.

3. What is scope of the Global Sirolimus-eluting Stents Market report?
Ans: Global Sirolimus-eluting Stents Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Sirolimus-eluting Stents Market?
Ans: The important key players in the Global Sirolimus-eluting Stents Market are – STENTYS SA, iVascular SLU, nano Therapeutics Pvt. Ltd, S3V Vascular Technologies, Meril Life Sciences Pvt. Ltd., Micell Technologies, Inc., B. Braun Melsungen AG, SMT, Eurocor Tech GmbH, Boston Scientific Corporation, Medtronic, Inc., Abbott Laboratories, Biosensors International Group, Biotronik, Lepu Medical Technology, Terumo Medical Corporation, Cook Medical, and Shandong JW Medical Systems.

5. What is the study period of this Market?
Ans: The Global Sirolimus-eluting Stents Market is studied from 2023 to 2030.